Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 23267801)

1.

Liver transplantation from hepatitis B surface antigen-positive donors.

Saidi RF, Jabbour N, Shah SA, Li YF, Bozorgzadeh A.

Transplant Proc. 2013 Jan-Feb;45(1):279-80. doi: 10.1016/j.transproceed.2012.05.077. Epub 2012 Sep 18.

PMID:
23267801
2.

Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.

Yu S, Yu J, Zhang W, Cheng L, Ye Y, Geng L, Yu Z, Yan S, Wu L, Wang W, Zheng S.

J Hepatol. 2014 Oct;61(4):809-15. doi: 10.1016/j.jhep.2014.05.003. Epub 2014 May 10.

PMID:
24824283
3.

Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.

Loggi E, Micco L, Ercolani G, Cucchetti A, Bihl FK, Grazi GL, Gitto S, Bontadini A, Bernardi M, Grossi P, Costa AN, Pinna AD, Brander C, Andreone P.

J Hepatol. 2012 Mar;56(3):579-85. doi: 10.1016/j.jhep.2011.09.016. Epub 2011 Oct 23.

PMID:
22027583
4.

[A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].

Ju WQ, He XS, Wang DP, Deng RH, Wu LW, Guo ZY, Zhu XF, Huang JF.

Zhonghua Gan Zang Bing Za Zhi. 2012 Jan;20(1):14-6. doi: 10.3760/cma.j.issn.1007-3418.2012.01.006. Chinese.

PMID:
22464699
5.

Low prevalence of HBV DNA in the liver allograft from anti-HBc-positive donors: a single-center experience.

Pan JJ, Oh SH, Soldevila-Pico C, Nelson DR, Liu C.

Clin Transplant. 2011 Jan-Feb;25(1):164-70. doi: 10.1111/j.1399-0012.2010.01211.x.

6.

Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.

Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, Gigou M, Shouval D, Dussaix E.

Gut. 2002 Jan;50(1):95-9.

7.

Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.

Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.

Clin Transplant. 2011 Jan-Feb;25(1):E77-81. doi: 10.1111/j.1399-0012.2010.01329.x. Epub 2010 Oct 11.

PMID:
21039887
8.

Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database.

Li Z, Hu Z, Xiang J, Zhou J, Yan S, Wu J, Zhou L, Zheng S.

Liver Transpl. 2014 Jan;20(1):35-45. doi: 10.1002/lt.23774. Epub 2013 Dec 12.

9.

Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.

Nery JR, Nery-Avila C, Reddy KR, Cirocco R, Weppler D, Levi DM, Nishida S, Madariaga J, Kato T, Ruiz P, Schiff E, Tzakis AG.

Transplantation. 2003 Apr 27;75(8):1179-86.

PMID:
12717200
10.

High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.

Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):203-8. doi: 10.1097/MPG.0b013e3181819ad4.

PMID:
19179883
11.

Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.

Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.

Biol Blood Marrow Transplant. 2010 Jun;16(6):809-17. doi: 10.1016/j.bbmt.2009.12.533. Epub 2010 Jan 7.

12.

Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors.

Choi Y, Choi JY, Yi NJ, Lee K, Mori S, Hong G, Kim H, Park MS, Yoo T, Suh SW, Lee HW, Lee KW, Suh KS.

Transpl Int. 2013 Dec;26(12):1173-83. doi: 10.1111/tri.12177. Epub 2013 Oct 17.

PMID:
24131436
13.

Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.

Holt D, Thomas R, Van Thiel D, Brems JJ.

Arch Surg. 2002 May;137(5):572-5; discussion 575-6.

PMID:
11982471
14.

Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.

Donataccio D, Roggen F, De Reyck C, Verbaandert C, Bodeus M, Lerut J.

Transpl Int. 2006 Jan;19(1):38-43.

PMID:
16359375
15.

Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.

Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN; Liver Match Investigators.

J Hepatol. 2013 Apr;58(4):715-23. doi: 10.1016/j.jhep.2012.11.025. Epub 2012 Nov 28.

PMID:
23201239
16.
17.

Kidney transplantation from hepatitis B surface antigen positive donors into hepatitis B surface antibody positive recipients: a prospective nonrandomized controlled study from a single center.

Jiang H, Wu J, Zhang X, Wu D, Huang H, He Q, Wang R, Wang Y, Zhang J, Chen J.

Am J Transplant. 2009 Aug;9(8):1853-8. doi: 10.1111/j.1600-6143.2009.02707.x. Epub 2009 Jun 16.

18.

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.

Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.

Liver Transpl. 2001 Jun;7(6):513-7.

19.

Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor.

Blaich A, Manz M, Dumoulin A, Schüttler CG, Hirsch HH, Gerlich WH, Frei R.

Transfusion. 2012 Sep;52(9):1999-2006. doi: 10.1111/j.1537-2995.2011.03537.x. Epub 2012 Feb 8.

20.

De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.

Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.

Liver Transpl. 2001 Jan;7(1):51-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk